Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 27, 2026

EDSA — Edesa Biotech, Inc. Dilution Risk Tracker

Track EDSA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EDSA — Get alerts when the score changes →

As of October 27, 2026, Edesa Biotech, Inc. (EDSA) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Edesa Biotech, Inc. has a market capitalization of $25.26M, 9.64M shares outstanding, 30 institutional holders tracked. Stored dilution-related fields include 745.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
70
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
📜 Warrant Exercise model 15%
• Warrant overhang: 7.7% of shares outstanding
🔔 Track EDSA — Get forecast alerts →

Market Data

Market Cap$25.26M
Shares Outstanding9.64M
Float3.85M
Cash$10.80M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding9.64MVerified float table or market cache
Public Float3.85MVerified float table or market cache
Market Cap$25.26MMarket data cache
Cash Runway19.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants745.3KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

EDSA SEC Filing Activity — Last 12 Months

Shares outstanding reported by EDSA on the cover page of its latest 10-K/10-Q: 9.64M as of August 13, 2026.

DilutionWatch recorded 2 registration or prospectus documents for EDSA (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)1Aug 20, 2026
424B3prospectus (resale / ATM)1Jul 13, 2026
EFFECTSEC declared a registration effective1Jul 14, 2026
8-Kcurrent report (material event)9Oct 23, 2026
10-Qquarterly report2Aug 13, 2026
DEF 14Aproxy statement1Apr 03, 2026
SC 13D/Aamended >5% holder filing2Aug 25, 2026
3initial insider ownership4May 15, 2026
5annual insider ownership21Oct 06, 2026

Institutional Holdings

QoQ: ↑ 7.9% shares (2026Q1 vs prior)
30 institutional holders · 3.30M shares
#1 PERCEPTIVE ADVISORS LLC 1.13M shares
#2 Velan Capital Investment Management LP 827.5K shares
#3 Rubric Capital Management LP 687.5K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest161.3K
Days to Cover3.5
% of Float4.2%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-08-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual EDSA Dilution Snapshot

Edesa Biotech, Inc. (EDSA) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

EDSA's DilutionScore is currently 52/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 55/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 27, 202652/100HIGH27 days
Aug 22 – Sep 30, 202655/100HIGH40 days
Aug 14 – Aug 21, 202649/100MEDIUM7 days
Jul 30 – Aug 13, 202652/100HIGH15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

Share count history for EDSA is tracked from verified regulatory filings.

Date Shares Outstanding Public Float Change
Apr 24, 2026———
Apr 10, 20268.89M3.48M▲ 9.93%
Mar 27, 20268.35M3.16M▲ 0.08%
Mar 26, 20268.35M3.16M▼ 0.03%
Mar 23, 20268.35M3.16M▼ 11.39%
Mar 19, 20268.35M3.57M▼ 13.64%
Mar 15, 20268.35M4.13M▼ 2.16%
Mar 14, 20268.35M4.22M▼ 0.05%
Mar 09, 20268.35M4.22M▼ 2.93%
Mar 08, 20268.35M4.35M▼ 10.41%
Mar 05, 20268.35M4.86M▲ 2.25%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track EDSA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment EDSA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking EDSA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for EDSA
EDSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.